San Francisco, CA, United States of America

Joshua Pollack

USPTO Granted Patents = 7 

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 307(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Joshua Pollack

Introduction

Joshua Pollack is a notable inventor based in San Francisco, CA, who has made significant contributions to the field of immunology. With a total of seven patents to his name, Pollack's work focuses on enhancing immune responses and addressing immune-related conditions, such as cancer. His innovative approaches have the potential to impact therapeutic strategies in the medical field.

Latest Patents

Among his latest patents, Pollack has developed methods and compositions for the modulation of stimulatory and non-stimulatory myeloid cells. These patents provide techniques for enhancing immune responses and treating immune-related conditions by targeting non-stimulatory myeloid cells using antigen binding proteins, such as antibodies or their fragments. This innovative work represents a significant advancement in the treatment of cancer and other immune-related diseases.

Career Highlights

Throughout his career, Joshua Pollack has worked with various organizations, including Rawles LLC and the University of California. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research. Pollack's dedication to advancing medical science is evident in his extensive patent portfolio.

Collaborations

Some of Pollack's notable coworkers include Ramy Sammy Sadek and Edward Dietz Crump. Their collaborative efforts have further enriched the research environment and fostered innovation in their respective fields.

Conclusion

Joshua Pollack's contributions to immunology through his patents and collaborations highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in the treatment of immune-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…